EPS estimates on shares of International Flavors & Fragrances Inc. (NYSE: IFF), MetLife, Inc. (NYSE: MET) and Mindray Medical International Limited (NYSE: MR) were updated by analysts.
Goldman Sachs (NYSE:GS) raised their EPS on International Flavors & Fragrances Inc. (IFF). They have a “neutral” rating and a price target of $68.00 on the company.
Bank of America (NYSE:BAC) raised their EPS on MetLife, Inc. (MET). They have a “buy” rating on the company.
Jefferies (NYSE:JEF) raised their EPS on Mindray Medical International Limited (MR). They have a “buy” rating and a price target of $33.00 on the company.
Showing posts with label Mindray Medical. Show all posts
Showing posts with label Mindray Medical. Show all posts
Wednesday, May 18, 2011
Wednesday, May 11, 2011
EPS Est on (IFF) (MET) (MR) Updated
EPS estimates on shares of International Flavors & Fragrances Inc. (NYSE: IFF), MetLife, Inc. (NYSE: MET) and Mindray Medical International Limited (NYSE: MR) were updated by analysts.
Goldman Sachs (NYSE:GS) raised their EPS on International Flavors & Fragrances Inc. (IFF). They have a “neutral” rating and a price target of $68.00 on the company.
Bank of America (NYSE:BAC) raised their EPS on MetLife, Inc. (MET). They have a “buy” rating on the company.
Jefferies (NYSE:JEF) raised their EPS on Mindray Medical International Limited (MR). They have a “buy” rating and a price target of $33.00 on the company.
Goldman Sachs (NYSE:GS) raised their EPS on International Flavors & Fragrances Inc. (IFF). They have a “neutral” rating and a price target of $68.00 on the company.
Bank of America (NYSE:BAC) raised their EPS on MetLife, Inc. (MET). They have a “buy” rating on the company.
Jefferies (NYSE:JEF) raised their EPS on Mindray Medical International Limited (MR). They have a “buy” rating and a price target of $33.00 on the company.
Tuesday, May 10, 2011
Ratings on (LPX) (MR) (ROSE) (SAM) Upgraded
Ratings on Louisiana-Pacific Co. (NYSE: LPX), Mindray Medical International Limited (NYSE: MR), Rosetta Resources Inc. (NASDAQ: ROSE) and The Boston Beer Company, Inc. (NYSE: SAM) upgraded by analysts.
TD Newcrest upgraded Louisiana-Pacific Co. (LPX) from a “reduce” rating to a “hold” rating.
Oppenheimer upgraded Mindray Medical International Limited (MR) from a “perform” rating to an “outperform” rating. They have a price target of $32.00 on the company.
Wunderlich upgraded Rosetta Resources Inc. (ROSE) from a “hold” rating to a “buy” rating. They now have a price target of $57.00 on the company, up from $47.00.
HSBC (NYSE:HBC) upgraded The Boston Beer Company, Inc. SAM) from an “underweight” rating to a “neutral” rating.
TD Newcrest upgraded Louisiana-Pacific Co. (LPX) from a “reduce” rating to a “hold” rating.
Oppenheimer upgraded Mindray Medical International Limited (MR) from a “perform” rating to an “outperform” rating. They have a price target of $32.00 on the company.
Wunderlich upgraded Rosetta Resources Inc. (ROSE) from a “hold” rating to a “buy” rating. They now have a price target of $57.00 on the company, up from $47.00.
HSBC (NYSE:HBC) upgraded The Boston Beer Company, Inc. SAM) from an “underweight” rating to a “neutral” rating.
Subscribe to:
Posts (Atom)